CD4 and neoplasm: The incorporation of L7/L12 should also be accompanied by assessments of cytokine profiles, as increased secretion of IFN-gamma from CD4+ and CD8+ T cells indicates a favorable Th1-type immune response, which is beneficial for anti-tumor immunity (96).